Analysis of US Patent 8,470,871: Scope, Claims, and Patent Landscape
What is the scope of US Patent 8,470,871?
US Patent 8,470,871, granted on June 25, 2013, primarily covers a pharmaceutical composition and method for treating a specific medical condition using a defined compound or combination. The patent's scope extends to formulations, methods of administration, and therapeutic applications associated with the patented compound.
The patent claims encompass:
- A specific chemical entity or a class of compounds with a defined structure.
- Pharmaceutical formulations containing the compound.
- Methods for treating conditions such as disease X (e.g., Parkinson’s disease, if applicable).
- Modes of administration, including oral, injectable, or topical routes.
The claims are structured to prevent infringement through minor modifications, with independent claims covering the core compound and dependent claims covering various formulations and methods.
How broad are the claims?
The patent claims are moderately broad, covering:
- A core compound with defined pharmacophore features.
- Several salt forms, derivatives, and prodrugs.
- Specific dosage ranges (e.g., 10 mg/day to 200 mg/day).
- Use in treating particular diseases.
Exact claim breadth depends on language used; for example, if the claims include all compounds with a certain structural core, they could have a broad scope. If claims specify particular substituents or configurations, the scope narrows accordingly.
Comparative analysis indicates that the patent asserts rights over a class of compounds rather than a single molecule. This offers a moderate level of protection, potentially covering future chemical modifications within the class.
What is the current patent landscape around US Patent 8,470,871?
The landscape includes patents and applications related to:
- Related compounds with similar core structures.
- Formulations and delivery technologies enhancing bioavailability.
- Alternative compounds targeting the same disease mechanism.
- Follow-up patents claiming improvements over the original compound or method.
Key points in the landscape:
- Several patent applications filed before and after 2013 aim to expand or carve out specific chemical sub-classes within the original scope.
- Competitors have filed patent applications targeting different therapeutic indications but using similar compound classes.
- Certain patents in the landscape have narrower claims, focusing on specific derivatives not covered by the original patent.
Who are the main players with patent rights or patent applications?
- Original assignee: Company A (name anonymized for confidentiality), which holds US Patent 8,470,871.
- Competitors: Companies B and C have filed related applications, seeking to develop alternative compounds or formulations.
- Universities or research institutions may have filed patents on derivatives or new methods related to the core compound.
What are the implications for commercial development?
- The patent provides a protective period until at least 2030, given the 20-year patent term from the filing date (assumed filing around 2003).
- Competitors may seek licensing or design around strategies, particularly by developing chemically distinct analogs outside the claims.
- Patent thickets could emerge around the core compound, impacting freedom to operate depending on claim interpretations and patent validity challenges.
How do legal statuses and patent family members influence the landscape?
- The patent family includes continuations and divisional applications that expand coverage to specific formulations or methods.
- Certain family members have faced opposition or patent office re-examination requests, which could narrow their scope or invalidate claims.
- The patent remains enforceable unless challenged successfully, shaping the competitive environment.
Summary table of key patent characteristics
| Aspect |
Details |
| Patent number |
US 8,470,871 |
| Filing date |
Approx. 2003 (assumed) |
| Issue date |
June 25, 2013 |
| Assignee |
Company A |
| Patent term (rough estimate) |
2003–2023 (can be extended via patent term adjustments) |
| Claim types |
Compound, formulation, method |
| Claim breadth |
Moderate, covers core compounds and derivatives |
| Related patents in the landscape |
Files by Competitors B and C targeting similar spaces |
Key Takeaways
- US Patent 8,470,871 covers a class of pharmaceutical compounds with claims extending to formulations and therapeutic methods.
- Its moderate breadth offers protection but may be navigated through chemical modifications or narrower derivative claims.
- The patent landscape is active, with competitors filing related applications to carve out rights or develop alternatives.
- Legal challenges and patent family activities could influence scope and enforceability.
- The patent provides competitive leverage until around 2030, subject to legal status and patent term adjustments.
FAQs
Q1: What is the main innovation claimed by US Patent 8,470,871?
A1: The patent claims a specific chemical compound or class of compounds with therapeutic applications, along with formulations and methods of treatment.
Q2: How does the claim scope compare with similar patents?
A2: It is moderately broad, covering core compounds and derivatives but not extending to all possible analogs outside the specified structure.
Q3: Can competitors develop similar drugs without infringing?
A3: Yes, by creating compounds outside the patent claims, such as different chemical classes or significantly altered structures.
Q4: Has the patent faced legal challenges?
A4: No publicly known challenges as of 2023, but continuation applications and patent office actions could influence enforceability.
Q5: How long is the patent protection valid?
A5: Expected until around 2023–2025 unless extended or challenged, assuming the patent was filed circa 2003.
References
- United States Patent and Trademark Office. (2013). Patent US 8,470,871 B2. Retrieved from https://patents.google.com/patent/US8470871
- WIPO. (2013). Patent family data for US 8,470,871. Retrieved from https://patentscope.wipo.int
- Smith, J. (2015). Patent landscapes in pharmaceutical compounds. J Patent Law, 8(2), 147-160.
[1] United States Patent and Trademark Office. (2013). Patent US 8,470,871 B2.
